General estimates indicate that individuals carrying a single APOE ε4 allele have a 2-to-4-fold increased risk of AD, whereas homozygous carriers exhibit an approximately 8-to-12-fold elevated risk. This evidence concerns the gene APOE and Alzheimer disease.